PL355606A1 - Transdermalne systemy terapeutyczne o ulepszonej trwałości i sposób ich wytwarzania - Google Patents

Transdermalne systemy terapeutyczne o ulepszonej trwałości i sposób ich wytwarzania

Info

Publication number
PL355606A1
PL355606A1 PL00355606A PL35560600A PL355606A1 PL 355606 A1 PL355606 A1 PL 355606A1 PL 00355606 A PL00355606 A PL 00355606A PL 35560600 A PL35560600 A PL 35560600A PL 355606 A1 PL355606 A1 PL 355606A1
Authority
PL
Poland
Prior art keywords
production
improved stability
transdermal therapeutic
therapeutic systems
systems
Prior art date
Application number
PL00355606A
Other languages
English (en)
Other versions
PL198323B1 (pl
Inventor
Walter Muller
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26007565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL355606(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10054713A external-priority patent/DE10054713C2/de
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of PL355606A1 publication Critical patent/PL355606A1/pl
Publication of PL198323B1 publication Critical patent/PL198323B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
PL355606A 1999-11-29 2000-11-24 Transdermalny system terapeutyczny zawierający wrażliwe na utlenianie substancje czynne i sposób jego wytwarzania PL198323B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19957401 1999-11-29
DE10054713A DE10054713C2 (de) 1999-11-29 2000-11-04 Transdermale Therapeutische Systeme mit verbesserter Stabilität und ein Verfahren zu ihrer Herstellung
PCT/EP2000/011692 WO2001039753A1 (de) 1999-11-29 2000-11-24 Transdermale therapeutische systeme mit verbesserter stabilität und ein verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
PL355606A1 true PL355606A1 (pl) 2004-05-04
PL198323B1 PL198323B1 (pl) 2008-06-30

Family

ID=26007565

Family Applications (1)

Application Number Title Priority Date Filing Date
PL355606A PL198323B1 (pl) 1999-11-29 2000-11-24 Transdermalny system terapeutyczny zawierający wrażliwe na utlenianie substancje czynne i sposób jego wytwarzania

Country Status (21)

Country Link
US (1) US6699498B1 (pl)
EP (1) EP1233763B1 (pl)
JP (1) JP5753645B2 (pl)
CN (1) CN1195506C (pl)
AR (1) AR026621A1 (pl)
AT (1) ATE245972T1 (pl)
AU (1) AU779523B2 (pl)
BR (1) BRPI0015939B8 (pl)
CA (1) CA2396686C (pl)
CZ (1) CZ295031B6 (pl)
DK (1) DK1233763T3 (pl)
ES (1) ES2204732T3 (pl)
HU (1) HU228822B1 (pl)
IL (1) IL149812A0 (pl)
MX (1) MXPA02005292A (pl)
NZ (1) NZ519069A (pl)
PL (1) PL198323B1 (pl)
PT (1) PT1233763E (pl)
RU (1) RU2266735C2 (pl)
TW (1) TWI272108B (pl)
WO (1) WO2001039753A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20060263419A1 (en) * 2002-03-12 2006-11-23 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
US20060216336A1 (en) * 2002-05-07 2006-09-28 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
ES2239196T3 (es) * 2002-12-02 2005-09-16 Schwarz Pharma Ag Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson.
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
TW200514582A (en) * 2003-10-31 2005-05-01 Hisamitsu Pharmaceutical Co Transdermal preparation and method for reducing side effect in pergolide therapy
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
US8563031B2 (en) * 2010-05-27 2013-10-22 Absize, Inc. Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
DE102017104026A1 (de) 2017-02-27 2018-08-30 Lts Lohmann Therapie-Systeme Ag Nicotin enthaltendes transparentes transdermales therapeutisches System
US20220257528A1 (en) * 2019-06-14 2022-08-18 Hisamitsu Pharmaceutical Co., Inc. Rotigotine-containing patch

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103117A (en) * 1980-01-19 1981-08-18 Nitto Electric Ind Co Ltd Stabilized plaster containing drug
JPS60199832A (ja) * 1984-03-22 1985-10-09 Nitto Electric Ind Co Ltd 抗酸化性外用製剤
FR2619388A1 (fr) * 1987-08-14 1989-02-17 Rhone Poulenc Chimie Article stratifie souple pour adhesif de transfert
JPH01249885A (ja) * 1988-03-30 1989-10-05 Narisu Keshohin:Kk 脂質の酸化防止剤
JP2788754B2 (ja) * 1989-05-12 1998-08-20 日東電工株式会社 シート状経皮吸収デバイス
JPH03232817A (ja) * 1990-02-07 1991-10-16 Showa Yakuhin Kako Kk 貼付剤
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
JP2869167B2 (ja) * 1990-08-09 1999-03-10 日東電工株式会社 徐放性貼付製剤
JP3723229B2 (ja) * 1991-03-12 2005-12-07 武田薬品工業株式会社 外用貼付剤
JP3034077B2 (ja) * 1991-04-19 2000-04-17 久光製薬株式会社 メラニン抑制貼付剤
JPH05306227A (ja) * 1992-04-27 1993-11-19 Lion Corp 徐放性口腔内疾患治療剤
JPH0624969A (ja) * 1992-07-09 1994-02-01 Teikoku Seiyaku Co Ltd ケトプロフェン含有外用貼付剤
DE4224325C1 (de) * 1992-07-23 1994-02-10 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige Wirkstoffe und Verfahren zu seiner Herstellung
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
IL109539A0 (en) 1994-05-03 1994-08-26 Yissum Res Dev Co Substained-release pharmaceutical system for the delivery of antioxidants
JP3157082B2 (ja) * 1994-09-22 2001-04-16 昭和薬品化工株式会社 医療用パック型製剤用基剤および医療用パック型製剤
JP3117619B2 (ja) * 1995-06-07 2000-12-18 花王株式会社 （メタ）アクリル酸系（共）重合体の製造方法
JP3361674B2 (ja) * 1995-11-08 2003-01-07 日本カーバイド工業株式会社 医療用粘着剤組成物
FR2744368B1 (fr) * 1996-02-02 1998-04-24 Fabre Pierre Dermo Cosmetique Composition dermocosmetique contenant du retinal
DE19700913C2 (de) * 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen
US6017950A (en) * 1997-08-05 2000-01-25 Millennium Pharmaceuticals, Inc. Methods for controlling gram negative bacteria in mammals
GB9800526D0 (en) * 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体

Also Published As

Publication number Publication date
CA2396686C (en) 2008-07-08
EP1233763B1 (de) 2003-07-30
HU228822B1 (en) 2013-05-28
AR026621A1 (es) 2003-02-19
RU2266735C2 (ru) 2005-12-27
BR0015939A (pt) 2002-08-20
BR0015939B1 (pt) 2013-10-08
US6699498B1 (en) 2004-03-02
PT1233763E (pt) 2003-11-28
ATE245972T1 (de) 2003-08-15
JP5753645B2 (ja) 2015-07-22
EP1233763A1 (de) 2002-08-28
CZ20021867A3 (cs) 2002-11-13
NZ519069A (en) 2004-06-25
DK1233763T3 (da) 2003-10-20
CA2396686A1 (en) 2001-06-07
MXPA02005292A (es) 2002-12-11
CN1402633A (zh) 2003-03-12
CZ295031B6 (cs) 2005-05-18
JP2003515554A (ja) 2003-05-07
HUP0203318A3 (en) 2004-06-28
AU2162301A (en) 2001-06-12
PL198323B1 (pl) 2008-06-30
AU779523B2 (en) 2005-01-27
ES2204732T3 (es) 2004-05-01
IL149812A0 (en) 2002-11-10
CN1195506C (zh) 2005-04-06
RU2002118325A (ru) 2004-02-20
TWI272108B (en) 2007-02-01
HUP0203318A2 (hu) 2003-02-28
WO2001039753A1 (de) 2001-06-07
BRPI0015939B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
HUP0203318A3 (en) Transdermal therapeutic systems with improved stability and a method for the production thereof
PL351687A1 (en) Polyolefins and method for the production thereof
AU3162001A (en) Medicament, a method for its production and the use thereof
HUP0202027A2 (en) Electroluminescent device and method for the production thereof
IL143349A0 (en) Azepinoindole derivatives, the production and use thereof
ZA200000842B (en) Method and system for administering a medication.
IL153273A0 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
HUP0200189A3 (en) Transdermal therapeutic system with nicotine
IL150330A0 (en) A method and system for representing gemstones or the like
PL350190A1 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
AU2351001A (en) Stent and method for the production thereof
HK1052155A1 (zh) 高純度聚合物顆粒及其生產方法
GB0003653D0 (en) Segmented transdermal dosage unit
AU2002247690A1 (en) Transdermal therapeutic system containing testosterone and method for the production thereof
HUP0104942A3 (en) Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments
AU5208200A (en) Screwed connection, fastener for said connection and method for the production thereof
HK1048889A1 (zh) 部件及其製造方法
GB9924549D0 (en) Filter materials and methods for the production thereof
HUP0102576A3 (en) Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
AU7563800A (en) Marsh-mallow and the marsh-mallow production technique
AU2001289844A1 (en) Amifostine-monohydrate and a method for the production thereof
HK1041026A1 (en) Vancoresmycin, a process for its production and its use as a pharmaceutical
HK1041912A1 (zh) 建築用台架組件及生產方法
HUP0102370A3 (en) Mumbaistatin, a process for its production and its use as a pharmaceutical
AU1021799A (en) Tubing piece and a method for the production thereof